Supernus Pharmaceuticals : 2023 Annual Report
Dear Supernus Stockholder, We are very pleased with our performance in 2023 as we continued to successfully transition from our mature brands and set the stage to...
Stay updated with breaking news from Supplementary Data. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Dear Supernus Stockholder, We are very pleased with our performance in 2023 as we continued to successfully transition from our mature brands and set the stage to...
2023 ANNUAL REPORT To Our Shareholders, I want to welcome you to our first annual report...
Exhibit 99.1 News Release Contact: James Gherardi Corporate Communications 312-394-7417 ...
02.05.2024 - Exelon Corporation (Nasdaq: EXC) today reported its financial results for the first quarter of 2024. 'Through the first quarter, Exelon is on track for another year of operational excellence while delivering on our financial guidance,' said ...
CELL-BASED TECHNOLOGY PLATFORMS 2023 Annual Report ...